X

Posts

April 03, 2014

+
8:20 AM | New life for naltrexone and autism?
During the very earliest days of the life of this blog I posted about the opiate antagonist naltrexone (ReVia®) and some research on its history with autism in mind; in particular, the various emerging speculations on low dose naltrexone (LDN) (see here). Today I'm following up that entry based on the results of a systematic review by Ashok Roy and colleagues [1] on the value (or not) of naltrexone for "attenuating the core symptoms of autism spectrum conditions in […]

Roy A, Roy M, Deb S, Unwin G & Roy A (2014). Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review., Journal of intellectual disability research : JIDR, PMID:

Citation
1
1 Result